Raymond James reiterates NOV stock rating on strong balance sheet By Investing.com

Raymond James reiterated an Outperform rating on NOV with a $23 price target versus a current share price of $18.75, but the company also flagged weaker first-quarter 2026 expectations. NOV now expects about $2.05 billion in revenue and $177 million of adjusted EBITDA, both pressured by Middle East disruptions, including a $54 million revenue hit and $32 million EBITDA impact from the Iran War. The balance sheet remains solid with a current ratio of 2.42 and free cash flow yield of 13%, partially offsetting the near-term operational noise.

Analysis

The market is treating this as a transient geopolitical earnings hit, but the more important signal is that offshore and subsea capex is not being cut — it is being deferred and redirected. That matters because NOV’s backlog visibility and capacity expansion suggest the medium-term profit pool is shifting toward longer-cycle deepwater and replacement demand, while short-cycle Middle East exposure becomes a margin volatility source rather than an outright earnings destroyer. In other words, the stock can de-rate on headline risk even as the business mix improves over the next 12-24 months.

The second-order winner is the broader offshore equipment/value chain, not necessarily the upstream producers. If Middle East disruptions persist, customers will prioritize resilience over lowest cost, which typically benefits suppliers with installed base, service content, and bottlenecked manufacturing capacity. The Brazil pipe expansion is strategically important because it can become a scarce asset in a tight deepwater supply chain; that scarcity can support pricing power well before the added capacity is fully online.

Consensus is likely underestimating the asymmetry between near-term estimate cuts and balance-sheet optionality. With the market focused on a few quarters of EBITDA noise, the setup favors investors who can look through the cycle: downside is probably bounded by cash generation and valuation support, while upside comes from a cleaner 2026-2027 offshore cycle and any stabilization in geopolitics. The key contrarian point is that a "bad" quarter may be the best entry point if management confirms backlog conversion and no demand destruction beyond timing shifts.

The main risk is not the current revenue bridge; it is a prolonged rerouting of project timing that delays high-margin execution without restoring volume, which would pressure sentiment for 2-3 quarters. If Middle East uncertainty broadens or deepwater customers re-cut budgets, the expansion thesis becomes less compelling and the shares could stay cheap longer than expected. But if the company proves the disruption is a timing issue, the equity could re-rate quickly because operational leverage on normalized volumes is significant.

Key Decisions for Investors

• Long NOV on post-earnings weakness over a 3-6 month horizon; use the selloff to build a position if the stock trades at or below the low-$18s, with a target back toward the low-$20s as guidance uncertainty clears.
• Buy NOV Jan-2026 $20 calls or call spreads to express upside from backlog conversion and limited balance-sheet risk; this offers favorable convexity if the market stops capitalizing the Middle East noise.
• Pair trade: long NOV / short a higher-beta oil services peer with weaker backlog or more short-cycle exposure; this isolates the thesis that resilient offshore infrastructure should outperform commodity-sensitive service names during geopolitical disruption.
• Avoid chasing short-side momentum in GS after the maintained Sell view; use it only as a hedge against a broader oil-services disappointment, since the cleaner expression is company-specific NOV execution rather than a directional macro short.
• If management commentary confirms the Brazil expansion is fully booked into the next cycle, add on strength rather than weakness; that would be a signal that capacity scarcity is becoming a multi-year earnings lever, not just a capex story.